Journal History

2009 The inaugural issue was released. Pharmaceutics was published as a quarterly journal.
2013 Pharmaceutics was indexed in PubMed (Citations were available in PubMed, full-text was archived in PubMed Central).
2017 Pharmaceutics was indexed in Science Citation Index Expanded (SCIE).
Pharmaceutics announced the first edition of the Travel Award.
2018 Pharmaceutics received its first Impact Factor (3.746).
Pharmaceutics announced the first edition of the Young Investigator Award.
Pharmaceutics published its 500th paper.
2019 Pharmaceutics adopted a monthly publication schedule.
Pharmaceutics received its Impact Factor (2018) of 4.773.
Pharmaceutics became an affiliated journal of the Academy of Pharmaceutical Sciences (APS), Korean Society of Pharmaceutical Sciences and Technology (KSPST), Pharmaceutical Solid State Research Cluster (PSSRC), and Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG).
Pharmaceutics published its 1,000th paper.
2020 Pharmaceutics held the 1st International Electronic Conference.
Pharmaceutics established the following sections:
  • Nanomedicine and Nanotechnology;
  • Pharmaceutical Technology, Manufacturing and Devices;
  • Physical Pharmacy and Formulation;
  • Biopharmaceutics;
  • Drug Delivery and Controlled Release;
  • Pharmacokinetics and Pharmacodynamics;
  • Gene and Cell Therapy;
  • Drug Targeting and Design;
  • Biologics and Biosimilars;
  • Clinical Pharmaceutics.
2021 Pharmaceutics received its Impact Factor (2020) of 6.321, and the 5-Year Impact Factor was 6.734.
2022 Pharmaceutics published its 5,000th paper.

Editor-in-Chief

2009–present  Editor-in-Chief: Prof. Dr. Yvonne Perrie

Section Editor-in-Chief

2020–present  Section Editor-in-Chief: Prof. Dr. Yvonne Perrie for the section on Drug Delivery and Controlled Release
Section Editor-in-Chief: Prof. Dr. Beom Soo Shin for the section on Pharmacokinetics and Pharmacodynamics
Section Editor-in-Chief: Prof. Dr. Donatella Paolino for the section on Nanomedicine and Nanotechnology
Section Editor-in-Chief: Prof. Dr. Patrick J. Sinko for the section on Biopharmaceutics
Section Editor-in-Chief: Prof. Dr. Thierry Vandamme for the section on Pharmaceutical Technology, Manufacturing and Devices
Back to TopTop